These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6980625)

  • 1. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.
    Farmer T; Reading C
    Antimicrob Agents Chemother; 1982 Mar; 21(3):506-8. PubMed ID: 6980625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
    Stobberingh EE; Davies BI; van Boven CP
    J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
    Bedenić B; Zagar Z
    J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin and properties of beta-lactamase satellite bands seen in isoelectric focusing.
    Simpson IN; Plested SJ
    J Antimicrob Chemother; 1983 Aug; 12(2):127-31. PubMed ID: 6604722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].
    Chaïbi EB; Mugnier P; Kitzis MD; Goldstein FW; Acar JF
    Res Microbiol; 1995; 146(9):761-71. PubMed ID: 8584798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
    Lacroix JM; Lamothe F; Malouin F
    Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
    Piot P; Van Dyck E
    Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
    Neu HC
    Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.
    Farmer T; Reading C
    Drugs; 1986; 31 Suppl 3():70-8. PubMed ID: 3488199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
    Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
    Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
    Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A
    Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains.
    Kadry AA; Fouda SI; Elkhizzi NA; Shibl AM
    Int J Antimicrob Agents; 2003 Nov; 22(5):532-6. PubMed ID: 14602374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.
    Yokota E; Fujii T; Sato K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Apr; 29(4):696-8. PubMed ID: 3486631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.
    Eliasson I; Kamme C; Vang M; Waley SG
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.